Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer

International Journal of Cancer

Volumn 126, Issue 8, 2010, Pages 1817-1827

  Lee, Hyun Hee ^d   Son, Young Joon ^d   Lee, Won Hyeok ^d   Park, Young Woo ^a   Chae, Seoung Wan ^b   Cho, Wha Ja ^c   Kim, Young Min ^c   Choi, Hye Jeong ^c   Choi, Dae Hwa ^c   Jung, Seok Won ^c   Min, Young Joo ^c   Park, Soon Eun ^c   Lee, Byung Ju ^c,d   Cha, Hee Jeong ^c   Park, Jeong Woo ^c,d  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Ulsan University College of Medicine   (South Korea)

^d University of Ulsan   (South Korea)

Author keywords

Angiogenesis; Colon cancer; Tristetraprolin; Tumor growth; VEGF

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; LUCIFERASE; MESSENGER RNA; TRISTETRAPROLIN; VASCULOTROPIN; SMALL INTERFERING RNA; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CLINICAL ARTICLE; COLON; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR VOLUME; ADENOCARCINOMA; ADENOMA; ANIMAL; BIOSYNTHESIS; CANCER STAGING; COLON TUMOR; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RNA STABILITY; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; COLONIC NEOPLASMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; TRISTETRAPROLIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77949898396     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24847     Document Type: Article

References (42)

1. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor in a potential tumor angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-848
2. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676
3. Brown L, Berse B, Jackman R, Tognazzi K, Guidi A, Dvorak H, Senger D, Connolly J, Schnitt S. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995; 26: 86-91.
4. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25. (Pubitemid 27076453)
5. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342 (Pubitemid 38702844)
6. EllisLM,TakahashiY,LiuW,ShaheenRM. Vascularendothelialgrowthfactorinhumancoloncancer: biologyandtherapeuticimplications.Oncologist2000;5:11-15.(Pubitemid30225451)
7. von Marschall Z, Cramer T, Höcker M, Finkenzeller G, Wiedenmann B, Rosewicz S. Dual mechanism of vascular endothelial growth factor upregulatlon by hypoxia in human hepatocellular carcinoma. Gut 2001; 48: 87-96. (Pubitemid 32042647)
8. ForsytheJA,JiangBH,IyerNV,AganiF,LeungSW,KoosRD,SemenzaGL. Activationofvascularendothelialgrowthfactorgenetranscriptionbyhypoxiainducible factor1.MolCellBiol1996;16:4604-4613(Pubitemid26272112)
9. LevyAP,LevyNS,IliopoulosO,JiangC,KaplinWG,Jr,GoldbergMA. RegulationofvascularendothelialgrowthfactorbyhypoxiaanditsmodulationbythevonHi ppei-Lindautumorsuppressorgene.KindeyInt1997;51:575-578(Pubitemid27088179)
10. Pages G, Pouyssegur J. Transcriptional regulation of the vascular endothelial growth factor gene: a concert of activating factors. Cardiovasc Res 2005; 65: 564-573 (Pubitemid 40138977)
11. ClaffeyKP,ShihSC,MullenA,DziennisS,CusickJL,AbramsKR,LeeSW,DetmarM. IdentificationofahumanVPF/ VEGF3'untranslatedregionmediatinghypoxiainducedmRNAstability.MolBiolCell1998;9: 469-481(Pubitemid28084138)
12. Wilusz CJ, Wormington M, Peltz SW. The cap-to-tail guide to mRNA turnover. Nature Rev Mol Cell Biol 2001; 2: 237-246
13. Levy NS, Chung S, Fumeaux H, Levy AP. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 1998; 273: 6417-6423 (Pubitemid 28144735)
14. Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, Pouyssegur J, Lamarre J, Feige JJ. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene 2004; 23: 8673-8680 (Pubitemid 39576474)
15. Cherradi N, Lejczak C, Desroches-Castan A, Feige JJ. Antagonistic functions of tetradecanoyi Phorbol Acetate-inducibiesquence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin. Mol Endocrinol 2006; 20: 916-930
16. Goldberg-Cohen I, Furneauxb H, Levy AP. A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J Biol Chem 2002; 277: 13635-13640 (Pubitemid 34967963)
17. Essafi-Benkhadir K, Onesto C, Stebe E, Monori C, Page G. Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing VEGF mRNA degradation. Mol Biol Cell 2007; 18: 4648-4658
18. Suswam E, Li Y, Zhang X, Gillespie GY, Li X, Shacka JJ, Lu L, Zheng L, King PH. Tristetraprolin down-regulates interleukin8 and vascular endothelial growth factor in malignant glioma cells. Cancer Res 2008; 68: 674-682 (Pubitemid 351206742)
19. Carrick DM, Blackshear PJ. Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines. Arch Biochem Biophys 2007; 462: 278-285
20. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995; 55: 237-241
21. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor. KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-3968
22. CascinuS,StaccioliMP,GaspariniG,GiordaniP,CatalanoV,GhiselliR,RossiC, BaldelliAM,GrazianoF,SabaV,MurettoP,CatalanoG. Expressionofvascularendothelialgrowthfactorcanpredictevent- freesurvivalinstageIIcoloncancer.ClinCancerRes2000;6:2803- 2807(Pubitemid30482120)
23. Marderosian M, Sharma A, Funk AP, Vartanian R, Masri J, Jo OD, Gera JF. Tristetraprolin regulates cyclin Dl and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling. Oncogene 2006; 25: 6277-6290 (Pubitemid 44564744)
24. Hau HH, Walsh RJ, Ogilvie RL, Williams DA, Reilly CS, Bohjanen PR. Tristetraprolin recruits functional mRNA decay complexes to ARE sequences. J Cell Biochem 2007; 100: 1477-1492
25. Dallas NA, Fan F, Gray MJ, Van Buren G, II, Lim SJ, Xia L, Ellis LM. Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells. Cancer Metastasis Rev 2007; 26: 433-441 (Pubitemid 350115100)
26. Chen C-YA, Shyu A-B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 1995; 20: 465-470
27. Barreau C, Paillard L, Osborne HB. AUrich elements and associated factors: are there unifying principles? Nucleic Acids Res 2006; 33: 7138-7150
28. BakheetT,FrevelM,WilliamsB,GreerW,KhabarK.ARED:humanAU-richelement- containingmRNAdatabaserevealsanunexpectedlydiversefunctionalrepertoireofencod edproteins.NucleicAcidsRes2001;29:246-254(Pubitemid32054460)
29. Young LE, Sanduja S, Bemis-Standoli K, Pena EA, Price RL, Dixon DA. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 2009; 136: 1669-1679
30. WaltenbergerJ,Claesson-WelshL,Siegbahn.A,ShibuyaM,HeldinCH. DifferentsignaltransductionpropertiesofKDRandFltl, tworeceptorsforvascularendothelialgrowthfactor.JBiolChem1994;269: 26988-26995(Pubitemid24332901)
31. BarleonB,SozzaniS,ZhouD,WeichHA,MantovaniA,MarméD. Migrationofhumanmonocytesinresponse-vascularendothelialgrowthfactor(VEGF) ismediatedviatheVEGFreceptorflt-1.Blood1996;87:3336-3343(Pubitemid26115364)
32. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989-991
33. Soker S, Takashima S, Miao HQ, Neufeld G, Kiagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92: 735-745 (Pubitemid 28155313)
34. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 1995; 87: 506-516
35. Masood R, Cai J, Zheng T, Smith DL, Hinten DR, Gill PS. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 2001; 98: 1904-1913
36. Dallas NA, Gray MJ, Xia L, Fan F, van Buren G, II, Gaur P, Samuel S, Lim SJ, Arumugam T, Ramachandran V, Wang H, Ellis LM. Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clin Cancer Res 2008; 14: 8052-8060
37. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993; 362: 841-844 (Pubitemid 23132159)
38. Korsisaari N, Kasman IM, Forrest WF, Pal N, Bai W, Fuh G, Peale FV, Smits R, Ferrara N. Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice. Proc Natl Acad Sci USA 2007; 104: 10625-10630 (Pubitemid 47185715)
39. DuBoisRN,McLaneMW,RyderK,LauLF,NathansD.Agrowthfactor- induciblenuclearproteinwithanovelcysteine/histidinerepetitivesequence. JBiolChem1990;265:19185-19191(Pubitemid20378589)
40. LaiWS,StumpoDJ,BlackshearPJ.Rapidinsulin- stimulatedaccumulationofanmRNAencodingaproline-richprotein.JBiolChem1990;265: 16556-16563(Pubitemid20324539)
41. Varnum BC, Lim RW, Sukhatme VP, Herschman HR. Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene 1989; 4: 119-120
42. CarballoE,LaiWS,BlackshearPJ. Feedbackinhibitionofmacrophagetumornecrosisfactor- alphaproductionbytristetraprolin.Science1998;281:1001-1005(Pubitemid28399252)